Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Safe Life increases production of its A400 Series respirators

Safe Life Corp., an innovative antimicrobial company dedicated to developing novel technologies that prevent the spread of infection and disease, announced today that it is ramping production of its comfortable, breathable, A400 Series respirator to help healthcare providers and government agencies address the global shortage of N95 respirators during the H1N1 pandemic.

15 Dec 2009

Dangers of H1N1 flu contaminated touch surfaces tour kicks-off

Dr. Bob Arnot kicks-off a national educational tour on the silent threat of H1N1 flu contaminated touch surfaces and the new biotechnology in EPA-registered SpectraSan 24 that kills bacteria, fungus and viruses including Influenza A (H1N1 or Swine Flu).

15 Dec 2009

CHPA comments on NIDA's Monitoring the Future survey

Following is a statement by Linda A. Suydam, D.P.A., president of the Consumer Healthcare Products Association (CHPA), regarding today's release of the National Institute on Drug Abuse's (NIDA's) Monitoring the Future survey:

15 Dec 2009

TV and video games can provoke violence among school students

Middle-school students are expressing their views on the key factors affecting youth violence, with more than 30 percent of them indicating that television, video games, movies and music provoke violence.

15 Dec 2009

CDC has distributed 3,177,900 doses of H1N1 flu vaccine to Pennsylvania till date

The federal Centers for Disease Control and Prevention, or CDC, has allocated a total of 3,177,900 doses of H1N1 flu vaccine to Pennsylvania to date, the state Department of Health said today.

15 Dec 2009

Supplements boost immune system and offer protection against seasonal flu

Accompanied by a chorus of coughs and sniffles, the winter season has arrived. "Protecting your health during this year's winter season should be a top priority for people," said Tom Tolworthy, CEO and Chief Health Enthusiast for The Vitamin Shoppe. "Many of our customers are being proactive in boosting their immune systems this time of year."

15 Dec 2009

Ethanol can worsen global health problems

Ethanol, often promoted as a clean-burning, renewable fuel that could help wean the nation from oil, would likely worsen health problems caused by ozone, compared with gasoline, especially in winter, according to a new study led by Stanford researchers.

15 Dec 2009

Scientists create Pandemic Influenza Planning Tool to model the spread of pandemic influenza

As communities brace for rising wintertime influenza cases, scientists are developing a mathematical and visual analytic toolkit to help health officials quickly analyze pandemics and craft better response strategies.

15 Dec 2009

IOM issues review of national vaccine strategy

Reuters: To strengthen U.S. national vaccine strategy, the country "needs to establish a permanent group that advises the government on vaccine safety and spend more money to address safety concerns about vaccines," according to a report released Friday by the Institute of Medicine.

15 Dec 2009

Teva Pharmaceutical Industries receives approval for newly revised prescribing information for AZILECT

Teva Pharmaceutical Industries, Ltd. today announced the U.S. Food and Drug Administration (FDA) approved the newly revised prescribing information for AZILECT® (rasagiline tablets) reducing medication and food restrictions.

15 Dec 2009

DeParle gets GOP cold shoulder on health reform

Politico: "Senate Republicans say they want to 'smoke out' Democratic senators who could help them bring down the health care bill, and so far, they think they've found one in Sen. Jim Webb. With all the attention focused on four other fence-sitting moderates, Webb has voted with Republicans six times on the first series of amendments on the Senate floor — giving GOP leaders some hope that the unpredictable Virginian could buck his party in the end and block the bill" (Raju, 12/14).

14 Dec 2009

ZYPREXA RELPREVV approved by FDA

The U.S. Food and Drug Administration (FDA) approved ZYPREXA RELPREVV (olanzapine) For Extended Release Injectable Suspension for the treatment of schizophrenia in adults, Eli Lilly and Company announced today.

14 Dec 2009

FDA grants EUA for DxNA’s 2009 H1N1 influenza virus diagnostic test

DxNA announced today that the United States Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for its 2009 H1N1 influenza virus diagnostic test for use in DxNA's GeneSTAT(TM) detection platform.

14 Dec 2009

Study supports the use of SinoFresh Nasal Spray to prevent and decrease H1N1 virus

SinoFresh HealthCare Products, Inc. announced the recent successful initial pilot animal study of the SinoFresh Nasal Spray product for use in preventing and decreasing the severity of H1N1 ("swine flu") virus.

14 Dec 2009

Heart attacks peak during winter months, finds research

Research has found that heart attacks peak during the winter months, and the prevailing hypothesis has been that cold temperatures stress the heart. But in 2004, researchers analyzed 12 years of Los Angeles County death certificates and found that heart attack deaths also rise in the balmy Los Angeles winters.

14 Dec 2009

National Vaccine Plan aims to protect Americans from vaccine-preventable illnesses

While vaccines help prevent many diseases in the United States, we lack immunization protection against several serious illnesses, says a new report from the Institute of Medicine that identifies priority areas for updating the National Vaccine Plan.

14 Dec 2009

Cubist Pharmaceuticals signs definitive agreement to acquire Calixa Therapeutics

Cubist Pharmaceuticals, Inc. a leading acute care therapeutics company, announced today the signing of a definitive agreement under which Cubist has agreed to acquire privately held Calixa Therapeutics Inc., a biopharmaceutical company focused on the development of novel antibiotics that address the expanding problem of multi-drug resistant Gram-negative pathogens.

14 Dec 2009

Scientists discover five genetic variants associated with lung disease

Scientists have discovered five genetic variants that are associated with the health of the human lung. The research by an international consortium of 96 scientists from 63 centres in Europe and Australia sheds new light on the molecular basis of lung diseases.

14 Dec 2009

Obese patients loosing moderate amount of weight improve their cardiovascular health, says study

Obese patients who lost a moderate amount of weight by eating less and exercising more improved their cardiovascular health, says a study at Washington University School of Medicine in St. Louis.

14 Dec 2009

Clinical trial of 2009 H1N1 influenza vaccine

HIV-infected adults currently are being recruited to participate in a clinical trial of 2009 H1N1 influenza vaccine. The study, sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health, will enroll approximately 240 men and women between the ages of 18 and 64.

13 Dec 2009